Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer

European Journal of Cardio-thoracic Surgery

Volumn 23, Issue 3, 2003, Pages 415-420

  Stilidi, Ivan ^a   Davydov, Michail ^a   Bokhyan, Vahan ^a   Suleymanov, Elkhan ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Esophageal cancer; Extended lymph node dissection; Ivor Lewis approach

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAFETY; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037336649     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1010-7940(02)00801-1     Document Type: Article

References (24)

1. Lewis I. The surgical treatment of carcinoma of the oesophagus. With special reference to a new operation for growths of the middle third. Br J Surg. 34:1946;18-31.
2. Bosset J.F., Gignoux M., Triboulet J.P., Tiret E., Elias D., Loza'ch P., Schloegel M., Mantion G., Mercier M., Bienvenu G. Randomized phase III clinical trial comparing surgery alone vs. preoperative combined radiochemotherapy (XRT-CT) in Stage I-II epidermoid cancer of the thoracic esophagus. Preliminary analysis: a study of the FFCD (French group) N 8805 and EORTC N 40881 (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol. 13:1994;A576.
3. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P.J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467.
4. Kelsen D.P., Ginsberg R., Pajak T.F., Sheahan D.G., Gunderson L., Mortimer J., Estes N., Haller D.G., Ajani J., Kocha W., Minsky B.D., Roth J.A. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984.
5. Ide H., Eguchi R., Nakamura T., Hayashi K., Hanashi T., Kobayashi A., Hanyu F., Murata Y., Yamada A. Evaluation of lymph node dissection for thoracic esophageal cancer based on preoperative staging. Peracchia A. Recent advances in diseases of the esophagus. Selected papers of the 6th World Congress of the ISDE. 1995;377-383 Monduzzi Editore, Bologna.
6. TNM classification of malignant tumors. 4th fully revised ed :1987;40-42 Springer, Berlin.
7. Metha C.L., Patel N.R. A network algorithm for performing Fisher's Exact Test in rxc contingency tables. J Am Stat Assoc. 78:1983;427-437.
8. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc. 53:1958;457-481.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
10. Akiyama H., Tsurumaru M., Udagawa H. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 220:(3):1994;364-373.
11. Fujita H., Kakegawa T., Yamana H., Shima I., Toh Y., Tomita Y., Yamasaki K., Higaki K., Naoke T. Mortality and morbidity rates, postoperative course, quality of life and prognosis after extended radical lymph node dissection for esophageal cancer. Comparison of three-field lymph node dissection and two-field lymph node dissection. Ann Surg. 222:(5):1995;654-662.
12. Collard J.M. Extensive lymph node clearance for cancer of the esophagus or cardia: merits and limits in reference to 5-year absolute survival. Hepatogastroenterology. 42:(2):1995;619-627.
13. Jacobi C.A. Systematic lymph node dissection in esophageal carcinoma preliminary results of a prospective randomised study. Zentralbl Chir. 121:(2):1996;110-115.
14. Skinner D.B., Little A.B. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 85:1983;59-71.
15. Baba M., Aikou T., Yoshinaka H., Natsugoe S., Fukumoto T. Long term results of subtotal esophagectomy with three-field lymph node dissection for carcinoma of the thoracic esophagus. Ann Surg. 219:(3):1994;310-316.
16. Isono K., Ochiai T., Koide Y. More or less surgery for esophageal cancer, indications for extended three-field lymph node dissection for esophageal cancer. Dis Esophagus. 7:1994;147-150.
17. Tabira Y., Kitamura N., Yoshioka M., Tanaka M., Nakano K., Toyota N., Mori T. Significance of three-field lymph node dissection for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate. J Cardiovasc Surg (Torino). 40:(5):1999;737-740.
18. Yong M.M., Deschamps C., Trastek V.F., Allen M.S., Miller D.L., Schleck C.D., Pairolero P.C. Esophageal reconstruction for benign disease: early morbidity, mortality, and functional results. Ann Thorac Surg. 70:2000;1651-1655.
19. Nurnberger H.R., Lohlein D. Experiences with the collar and thoracal anastomoses after subtotal esophagectomy regarding safety and complication rate. Zentralbl Chir. 119:(4):1994;233-239.
20. Svanes K., Stangeland L., Viste A., Varhaug J.E., Gronbech J.E., Soreide O. Morbidity, ability to swallow, and survival, after oesophagectomy for cancer of the oesophagus and cardia. Eur J Surg. 161:(9):1995;669-675.
21. Collard J.M. The stomach as an esophageal substitute after total or subtotal esophagectomy. 1997;Faculty of Medicine, Catholic University Louvain, Louvain.
22. Chu K.M., Law S.Y., Fok M., Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 174:1997;320-324.
23. Pera M., Cameron A.J., Trastek V.F., Carpenter H.A., Zinsmeister A.R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 104:1993;510-513.
24. Visbal A.L., Allen M.S., Miller D.L., Deschamps C., Trastek V.F., Pairolero P.C. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg. 71:2001;1803-1808.